Showing results (41-50 of 71) with videos related to
Sort By:
Pageof 8
Journal of the American Chemical Society|September 14, 2019
Water Networks Can Determine the Affinity of Ligand Binding to ProteinsJohn F Darby, Adam P Hopkins, Seishi Shimizu, et al.Bioorganic & Medicinal Chemistry|May 6, 2014
Probing linker design in citric acid-ciprofloxacin conjugatesStephen J Milner, Anna M Snelling, Kevin G Kerr, et al.Communications Chemistry|January 27, 2023
Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixturesLisa M Baker, Anthony Aimon, James B Murray, et al.Cell Reports|October 16, 2025
P-Rex1 limits the agonist-induced internalization of GPCRs independently of its Rac-GEF activityMartin J Baker, Elizabeth Hampson, Priota Islam, et al.Journal of Medicinal Chemistry|June 25, 2005
Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based designBrian W Dymock, Xavier Barril, Paul A Brough, et al.Chemistry & Biology|June 26, 2004
Structure-activity relationships in purine-based inhibitor binding to HSP90 isoformsLisa Wright, Xavier Barril, Brian Dymock, et al.Chemmedchem|February 3, 2025
Structure-Atropisomer Stability Relationship in Selective MCL-1 InhibitorsSzabolcs Sipos, Barbara Balazs, Tamas Gati, et al.Journal of Medicinal Chemistry|June 18, 2021
Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1BDavid Lee Walmsley, James B Murray, Pawel Dokurno, et al.Journal of Medicinal Chemistry|May 12, 2021
Structure-Guided Discovery of Potent and Selective DYRK1A InhibitorsCsaba Weber, Melinda Sipos, Attila Paczal, et al.ACS Omega|September 9, 2021
The Effect of Core Replacement on S64315, a Selective MCL-1 Inhibitor, and Its AnaloguesSzabolcs Sipos, Balázs Bálint, Zoltán B Szabó, et al.Pageof 8